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In the previous paper of this series (1) the isolation of two fractions of strep- 
tococcal nucleoproteins was described: the cytoplasmic particles (CP) and the 
S fraction, of smaller molecular size.  It was pointed out that so far neither 
fraction had been prepared chemically free of the other.  However, the immu- 
nologic  reactions  of  each  were  so  distinct  and  characteristic  that  the two 
fractions could be employed in serologic  tests in their present state of purity. 
Although the S fraction was shown by electrophoresis and ultracentrifugation 
to contain two molecular species,  presumably protein, the use of this prepa- 
ration in exploratory serologic work is indicated by the facts that this fraction 
has not been described before, and that the relative concentrations of the two 
components  of  S  axe  of  the  same  order  (33 and 67 per cent of their total, 
respectively). 
Since antibodies to these fractions had never been measured, it was necessary 
to determine their titer in the normal population.  Such tests were performed 
on the sera of newborn infants, older infants, children, and young adults.  For 
evaluation in streptococcal infections tests were done on a group of patients with 
scarlet  fever,  serial  specimens  being  taken  at  the  acute  and  convalescent 
stages and several months thereafter.  Finally, titrations were done on the sera 
of patients with active and quiescent rheumatic fever, and longitudinal studies 
were done during single or repeated rheumatic episodes.  For general corre- 
lation with the earlier work on measurement of streptococcal antibodies, anti- 
streptolysin tests were done on each serum tested. 
Methods and Materials 
The Preparation of Sera and Antigens.--The sera of newborn infants were prepared from 
blood collected from the umbilical cords in the Delivery Rooms of the Philadelphia General 
* The work described in this paper was aided by a grant from the Life Insurance Medical 
Research Fund. 
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Hospital.  The sera of older infants were collected at the Well-Baby Clinic of The Children's 
Hospital of Philadelphia.  These infants ranged in age from 6 months to 2 years.  The sera 
representing the antibody levels in normal children were those collected in the group of patients 
with scarlet fever mentioned below for the study of the serologic response in acute streptococcal 
infection.  Only sera collected within the first 3 days of the disease were taken to represent 
normal antibody levels.  The sera of young adults were collected at the Student Health Service 
of  the University of  Pennsylvania. 
For the study of antibody response to these antigens in acute streptococcal disease, blood 
specimens were collected from children with scarlet fever at the Philadelphia Hospital for Con- 
tagious  Diseases during the  first half-week and  during the 3rd week of the disease.  In a 
number of these cases, an additional specimen was drawn 4 months later. 
In the case of rheumatic patients the blood specimens were drawn at weekly, biweekly, or 
monthly intervals, depending on the severity of the rheumatic process, in correlation with the 
clinical studies to be described below. 
Blood specimens were collected with a minimum of sodium citrate as anticoagulant, in order 
to allow for the determination of the erythrocyte sedimentation rate, white blood count, and 
concentration of hemoglobin.  The plasma was drawn off each blood specimen and frozen 
soon  as  the  tests above had  been  completed.  When  a  specimen was to be tested, it was 
thawed, and cleared by centrifngation of the fibrinogen which had precipitated on freezing.  A 
single dilution of 1:8 or 1 : 16 was made of each serum, in sufficient amount to allow for the two 
complement fixation tests, the detection of anticomplementary sera, the antistreptolysin titer, 
and the antihyaluronidase titer (2).  It was then heated to 56°C. for 15 minutes to inactivate 
complement.  These dilutions were used within a few days,  and were kept frozen between 
tests. 
The S antigen was maintained in the refrigerator in the lyophllized state and was dissolved 
when needed.  In the case of CP desiccation was not feasible, because of poor resolution of the 
large particles.  The CP was maintained in suspension in the refrigerator with merthiolate 
added to a final concentration of 1 : 10,000.  There were no troublesome anticomplementary 
effects during many months of such storage. 
The Serologic Tests.--Complement fixation tests were performed by incubating 0.4 cc. of 
various dilutions of serum with 0.1 cc. of the antigen (at twice its minimal optimal concen- 
tration) and 0.1 cc. of complement, diluted to contain 1.3 to 1.5 units under the conditions of 
the test.  After 45 minutes of incubation at 37°C., 0.1 cc. of a 4 per cent suspension of sheep 
erythrocytes was added to each tube, together with 0.1 cc. of rabbit anti-sheep-erythrocyte 
serum, adjusted to contain 2 units of hemolysin in that volume.  The antigen-complement and 
the sensitized erythrocytes were each added as a mixture, using an automatic pipet.  At the 
end of half an hour of further incubation at 37°C. the degree of hemolysis was read as 0, weak, 
strong, or complete.  As a control on temperature effects in incubating, and because of the 
time required for the pipetting of reagents, at least one standard serum was included in each 
rack  of  every  test.  Each  test  with  each  antigen  involved about 450 sera, including the 
standard sera.  The usual precautions of complement tit.rations were taken, and several experi- 
mental sera of each test were repeated in the following one.  Finally, for more precise com- 
parison of titers in a given patient at different stages of activity of the rheumatic process, all 
sera of a  given patient were included within one set to be tested,  t 
The antistreptolysin tests were done exactly as suggested by Todd (3), since that is the 
technic  followed  in  almost  all  of  the  reported  studies  of  antistreptolysin titers.  Serum 
dilutions were made in volumes of 0.4 rather than 0.5 cc.~ in conformity with the other testa 
in this study. 
a The complement  used in this study was the lyovac complement of Sharp and Dohme~ Inc., 
to whom the author is indebted for generous gifts of this materisL ~:. N. ~ts  59 
The Study of the Patients and the Criteria of Activity of the Rheumatic Process.--The rheu- 
matic patients were studied in acute, convalescent, and quiescent stages of the disease.  They 
were usually seen first in the wards of The Children's Hospital of Philadelphia, or the Phila- 
delphia General Hospital.  Many of them were studied in the wards of the Children's Seashore 
House at Atlantic City during the chronic, active and the convalescent stages of the illness. 
They were then followed at the Rheumatic Fever Clinics of the first named institutions in the 
quiescent stage.  In some cases, of course, the entire cycle was repeated. 
The patients were examined at least every 2 weeks while in the acute or convalescent wards 
and at each visit to the Clinics.  These examinations included the following: symptoms--ano- 
rexia, headache, precordial, abdominal, or arthritic pain, cough, dyspnea, and epistaxis; physi- 
cal signs--cardiac rate and rhythm, distance of apex beat from the midline, murmurs, with 
distance of transmission of each, and other adventitious sounds, palpable thrills and friction 
rubs, hepatic enlargement and edema, rashes,  subcutaneous nodules, and chorea.  Laboratory 
examinations included the erythrocyte sedimentation rate, white blood cell count, and hemo- 
globin concentration.  The vital capacity was usually determined at biweekly intervals, and 
electrocardiograms were taken as required.  The erythrocyte sedimentation rate was done by 
a method described elsewhere (4).  It involved a series of readings of the erythrocyte level at 
5 minute intervals, in order to determine the rate of free fall of the corpuscles,  and a correction 
for the relative volume of erythrocytes. 
The patients selected for serologic study were, of course, only those in whom the diagnosis 
of active rheumatic fever was beyond doubt.  Very nearly all of these children had active 
rheumatic  carditis. 
The recording of clinical evidence of rheumatic activity in correlation with the serologic 
titers presented a problem.  A considerable part of the clinical data was kept in graphic form 
in the records of this investigation.  However, an attempt to present all such data in graphic 
form in this paper was abandoned because of the necessary complexity of such graphs.  On 
the other hand, the manifestations of active rheumatic disease are so protean that no one or 
two clinical signs can measure the activity in all cases.  The erythrocyte sedimentation rate 
is probably the most sensitive single indicator of activity of the rheumatic process,  but it has 
been shown that this test may be unreliable in adolescent and overweight children (4), in right- 
tided heart failure (5, 6), and in prolonged, full dosage of salicylates (7-9).  Finally, there are 
some patients in every series of sufficient sizewhose erythrocyte sedimentation rate is within 
normal  limits,  although  there  is  unquestionable  clinical evidence of  an  active rheumatic 
process. 
For the recording of the clinical evidence of the degree of rheumatic fever, therefore, it was 
decided to show the erythrocyte sedimentation rate, temperature, resting pulse rate, and such 
episodes as polyarthritis, carditis, and cardiac failure.  The criteria of quiescence of the rheu- 
matic process included the fall to a plateau level of the erythrocyte sedimentation rate, of the 
size and rate of the heart, and of murmurs and their extent of transmission; a stable pulse rate, 
absence of significant symptoms and signs, and general well being. 
P.ESULTS 
The Optimal Antigen Concentration  of the Fractions.--In order to use the two 
nucleoprotein fractions in large scale serologic tests it was necessary to ascertain 
that  the optimal range of concentration  of each fraction as antigen in comple- 
ment fixation tests was the same, regardless of the titer of the antiserum.  Table 
I  shows that such is the case for high and low titered sera of rheumatic patients. 
The same optimal concentrations were found to obtain also in tests using rabbit 
antistreptococcal  sera of high and  low titer. 60  STREPTOCOCCAL COMPLEMENT FIXATION 
The Antibody Levels to CP and S in Normal Subjects of Various Age Groups.-- 
Since nothing was known of the occurrence of these antibodies in human sera, 
determinations were carried out of the complement fixation titers to CP and S 
in sera of 35  neonatal infants, of 35  older infants ranging from 6  months  to 2 
years, of 70  children ranging from 4  to  15  years, and of 40  medical students; 
Comparative tests of antihemolysin were done in parallel.  The results of these 
tests are shown in the form of a  percentage frequency chart in Fig. 1. 
Fig. 1 shows that antibodies to all three streptococcal antigens under investi- 
gation are found in the sera of normal subjects.  Although the range of titers 
TABLE I 
The Comtancy of Optimal Antigen Titers of CP and S in Complement Fixation Tests 
¢er~as R~enma~ Sera of High and Low Tiler 
CP 
0.01 per cent solution 
0.005 
0.0025 
) .0013 
S 
0.2 per cent solution 
0.1 
0.05 
0.025 
0.013 
Serum1315  (active rheumatic) 
Dilution  1: 
32  64  128  256 
0 
0 
0 
W 
0 
0 
0 
0 
W 
0 
0 
0 
W 
0 
0 
0 
tr 
S 
512  1024 
0 
0 
0 
S 
C 
C 
C 
C 
C 
1910 
(quiescent rheumatic) 
Dilutioa 1: 
2 }48  $  16  32  64 
s  0  w  s  c 
s  0  w  s  c 
s  0  w  c  c 
S  W  S  C  C 
c  0  s  c  c 
c  0  w  c  c 
c  0  w  c  c 
C  W  S  C  C 
C  ac  c  i  c  c  b 
The degree of hemolysis Is recorded: O, none; tr, a trace; w, weak; s, strong; ac, almost 
complete; c, complete. 
differs among the three tests, certain broad similarities are seen.  In each test, 
a  considerable percentage of relatively high tilers is found in neonatal infants. 
After severn1 months, or a  year, the higher titers are no longer found except in 
a very few cases.  In childhood higher titers appear in all three tests, and among 
young adults the higher tilers occur with slightly greater frequency than  among 
children. 
The Antibody Response in Acute Streptococcal Disease.-- 
Since no epidemic of streptococcal infection occurred in the Philadelphia area during the 
course  of these studies, the patients chosen for examining  antibody levels in streptococcal 
infection were children with scarlet fever.  These children were admitted to the Philadelphia 
Hospital for Contagious Diseases within the first day or two of the disease.  The diagnosis was 
verified at the hospital, and the children were not treated with sulfonamides.  Sera drawn at .J 
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FIG. 1.  The frequency distribution, in percentage, of complement fixation liters to CP and 
S~ and of antistreptolysin titers, in sera of normal subjects of various age groups. 
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the  beginning and  at  the  end  of  the  3  week  hospitalization were compared to determine 
increases in antibodies in the course of the infection.  As can be seen by the distribution of 
normal titers in Fig. 1, the titers at the first bleeding varied widely.  Accordingly, the effect 
of the disease on the antibody level is recorded, in Table LI, in terms of individual increases, 
rather than of average titers. 
Table II shows that in all the tests 80 per cent or more of the patients showed 
at least a twofold rise in titer, so that an increase of antibody level in any of these 
three tests may be considered characteristic of this acute streptococcal infection. 
There was poor correlation among the changes of antibody titers to the respective 
antigens.  Although a few sera showed very little or no rise in the titerof all three 
antibodies, there were examples of sera in which one of the antibodies showed a 
greater  increase  in  titer  than  in  the  case  of  the  other  two.  This could be 
TABLE  II 
Porc,  er~age Frequency of Increases in Antibody  Titers to CP, S, and Hemolysin in the 
First 3 Weeks of a Group of 70 Cases of Scarlet Fever 
Increase in tlter 
None or too small to be significant  ............. 
2-fold ...................................... 
4-fold ...................................... 
8-fold ...................................... 
16-fold ..................................... 
32-fold or higher  ............................. 
CP 
20 
39 
22 
14 
4 
1 
ASL 
15  17 
66  37 
17  11 
2  8 
0  7 
0  20 
observed for any of the three antibodies, especially in the case of anti-CP and 
antihemolysin, in which the range of increase tended to be higher. 
In order to study the persistence of these antibodies after recovery from the 
streptococcal infection, sera were obtained from these patients 4 months after 
they  were  discharged  from  the  hospital.  Twenty  such  specimens  were 
obtained.  Comparison of the titers of these sera with those of the specimens 
drawn  at  3  weeks showed  that  the majority of titers  to each of the antigens 
remained elevated for at least that period of time.  In the case of the CP, 70 
per cent of the pairs of sera showed no significant change in titer.  In 10 per 
cent, there was a  twofold fall in titer, and in 20 per cent, there was a  twofold 
rise.  Anti-S antibodies showed as high a  titer after 4 months in 80 per cent, a 
fall in 10 per cent, and a  rise in 10 per cent.  The antistreptolysin titers were 
unchanged in 65 per cent of the pairs tested.  The 4-month specimens showed 
higher titers in 10 per cent of the pairs, and slightly lower titers in the remaining 
25 per cent.  In general the titer of all three antibodies was in the same range 
after 4 months of health as during the preceding episode of scarlet fever. 
Antibody  Titers  in Acute and Quiescent Rheumatic  Fever.raThe sera of 100 T. N. HARRIS  63 
| 
0 
i  ! 
o 
'-J "~I  ~JAIJ.OV 
e4 
e,l 
v 
e,l 
o  o  o  o 
P 
2 
Z 
3 64  STREPTOCOCCAL  COMPLEMENT  ~FIXATION 
children with active rheumatic fever were examined for antibodies to these three 
streptococcal antigens, as well as the sera of 81 rheumatic patients in the qui- 
escent stage of the disease.  The frequency with which various titers were found 
is shown in percentages in Fig. 2. 
Fig. 2 shows that the antibodies in all three tests were elevated in the great 
majority of active cases, in comparison with those of normal children shown in 
Fig.  1.  In the case of quiescent rheumatic patients fewer elevated titers  are 
found, but there are more of these than among the normal individuals. 
A  comparison of the distribution of titers in active rheumatic patients with 
those of normal controls of the same age group suggests a titer of 32 as a dividing 
line  between  the  anti-CP  fiters  of  normal  children  and  active  rheumatic 
patients, 8 for the anti-S titers, and 128 as the analogous antistreptolysin level. 
The significance of these levels and of the difference between titers of normal and 
acute rheumatic children is brought out in Table III. 
TABLE III 
Tilers of Normal, Aai~, Rt~ur,  w~i*, and OuV~sc~ Rt~urnati.  CMldra* against CP, 
S, and Hemolysin, in Pementages 
Normal children. 
Active rheumatic fever... 
Quiescent rheumatic fever. 
CP 
64 and 
Up to 32  above 
91  9 
13  87 
69  31 
Up to $  16 sad 
above 
87  13 
4  96 
73  27 
ASL 
256 and  Up to 128  above 
97  3 
17  83 
80  20 
Table III shows that a range of anti-CP titers exists which includes so high 
a percentage of normal children that, for streptococcal work, it can be considered 
the  upper  normal  limit,  and  that  the  ~eat  majority  of  active rheumatic 
subjects have titers above that level.  The same is true of anti-S titers.  The 
analogous  results  with  antistreptolysin  titers  confirm  those  recorded  in  the 
literature.  The  sera  of  quiescent  rheumatic  patients  show  a  much  smaller 
number  of  titers  above  the  upper  normal  limit,  but  more  than in the case 
of normal individuals.  The average intervals between the foregoing acute rheu- 
matic episode and the time of collection of serum from these quiescent rheumatic 
patients were  17  months. 
Antibody  Titers during Fluctuations in the S~erity of the Rheumatic Process.-- 
The great majority of the patients with acute rheumatic fever were followed into 
the  stage of quiescence.  A  few had continuous  rheumatic activity either of 
fulminating severity ending in death, or of a low grade.  A number, however, 
ran a  classical polycyclic course with clearly defined recurrences or changes in 
clinical  estimate  of  rheumatic  activity.  In  the  single  rheumatic  episodes T.  N.  IIAEE~  65 
studied the titers of all three antibodies did not decline as the clinical activity 
of the disease subsided, but remained elevated for months after complete qui- 
escence  of the rheu~aatic process, in the absence of any clinical streptococcal 
infection.  The patients with a  polycyclic course afforded an opportunity to 
correlate antibody titers with variations in degree of rheumatic activity.  The 
charts of three such patients, shown in Fig. 3, reveal that, although the titers 
vary during the course of the rheumatic infection, there is no correlation with 
the clinical changes used to evaluate the severity of rheumatic fever.  In -one 
of the cases shown had sufficient time elapsed between recurrences for the titers 
to fall to normal levels. 
DISCUSSION 
The presence of the antibodies measured in these studies in normal seta, and 
their concentrations at various age groups, are a consequence of the prevaleace of 
the hemolytic streptococcus in the human throat and of the breadth of speci- 
ficity of the antigens.  After several months or a year the infant has lost the 
streptococcal antibodies derived from the maternal blood!; the titers are quite 
low at that age.  In childhood, howex~r, as opportunity for contact with the 
ubiquitous streptococcus increases, higher titers appear  and these are again 
slightly higher in young adults.  Among the antistreptolysin values, the com- 
parison of titers between neonatal life, later infancy, and childhood is in good 
agreement with that reported for that test by Gordon and Janney (10). 
The prevalence of the hemolytic streptococcus and the broad specificity of 
these antigens are also th  e basis for the prolonged maintenance of elevated titers 
after acute streptococcal or rheumatic disease.  In this case it is probable that 
minute amounts of antigens, produced by streptococci too few in number to 
excite an inflammatory reaction, suffice to act as "boosters" to maintain or raise 
a titer already elevated by disease.  In the case of both streptococcal and rheu- 
matic infection, Mote and 3ones (11) have shown that antistreptolysin titers 
may remain elevated for as long a period as 1 year, without clinical infection by 
the streptococcus.  Solomon (12) has shown the same effect in streptococcal 
infection,  and  Yannet  and  Leibovitz  (I3)  had  similar  results  with  anti- 
fibrinolysin in streptococcal disease.  In the studies reported here anti-CP and 
anti-S titers were followed for 4 months after streptococcal infection.  At the 
end of that time the average titers were the ~me as at the height of the disease. 
Following acute rheumatic infections there was a better opportunity to observe 
the rate of fall of the antibodies to CP and S.  These antibody titers could 
remain elevated for many months after the evidence of rheumatic activity had 
subsided.  It is very likely that the greater percentage of elevated titers in the 
quiescent rheumatic group than among normal controls was due to the same 
phenomenon as that which keeps these titers above normal after streptococcal 
infection, and not to any characteristic reaction of the quiescent rheumatic 
patient to these antigens. 55  STREPTOCOCCAL  COMPLEMENT  I~AXATION 
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The factors which account for the prevalence and persistence of these anti- 
bodies also make it neces~ry to assume an upper limit of normal titers which 
does not actually include the highest titers among normal subjects.  As striking 
as  is  the  contrast  in  distribution  of  titers  between  active  rheumatics aud 
controls, it would be impossible to demonstrate it if one stipulated that the 
upper limit accepted for the normal population include all the titets found in 
that group.  The epidemiology of the streptococcus makes it necessary to set 
the  upper  limit  of  normal  at  a  titer  which  includes only 85 or 90 per cent 
of normal sere tested.  Even without accepting the levels indicated in Table 
HI as upper limits of normal for the respective antibody titers, the difference 
in distribution of titers between normal subjects and active rheumatics is strik- 
ing, and statistically significant.  The serologic tests with CP and S confirm the 
suggestion derived from antifibrinolysin and  antistreptolysin tests  that  the 
active rheumatic patient is one in whom streptococci are present in numbers 
comparable to those in an acute streptococcal infection. 
It is not possible to be certain at present whether either of the new tests is 
preferable to the antistreptolysin test for general use,  The antiS titers show 
the greatest difference between the acute and quiescent phase groups.  Whether 
this difference is sufficiently great to indicate the use of anti-S complement 
fixation for semiroutine work will be decided as additional serologic  tests are 
done. 
The question inevitably arises as to the r61e of CP and S in the pathogenesis 
of rheumatic fever.  It should be pointed out that if the pathogenesis of rheu- 
matic fever involves sensitization, it is possible that the sensitizing agent will 
not be detected by serologic  tests, because there is no necessary quantitative 
correlation between the degree of sensitization and the titer of humoral anti- 
bodies to a  given substance.  Especially in the case of streptococcal immu- 
nology, the  disturbing factor of prevalence  of Subclinical  contacts with the 
organism would make the serologic identification of a streptococcal sensitizing 
agent very unlikely, should such an agent exist in rheumatic fever.  The work 
presented here should not be regarded, therefore, as an examination of the CP 
and S as possible pathogenetic agents in rheumatic fever, but rather as a sero- 
logic exploration of sera of normal, streptococcal, and rheumatic subjects by 
these new antigens. 
SD'MMAgY 
Complement-fixing antibodies to the cytoplasmic particles (CP) and to the 
S fraction of streptococcal nucleoproteins are present in normal human sera, 
the range of concentrations varying among the age groups. 
The titer of these antibodies rises  between the first half-week and the 3rd 
week of scarlet fever, in more than 80 per cent of the cases.  The titers then 
remain elevated for at least 4 months. 70  STREPTOCOCCAL  COMPLEMENT  FIXATION 
In children, 91 per cent of the normal sera examined showed anti-CP titers 
up to 32; 87 per cent of sera in active rheumatic disease had titers above this 
level.  Corresponding data  with  S  fell in  the same range of percentage dis- 
tribution. 
Anti-CP and anti-S titers remained elevated long after the rheumatic process 
had reached quiescence.  No  correlation of serologic titer with the degree of 
clinical activity was found in the case of either antibody. 
The author wishes to thank Dr. A. C. LaBoccetta, of the Philadelphia Hospital for Con- 
tagious Diseases, for permission to obtain the serum specimens of the patients with scarlet 
fever, and Dr. Werner Henle, of The Children's Hospital of Philadelphia, for the serum speci- 
mens of older infants and young adults. 
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